About: Point-of-Care Microdevices for Blood Plasma Analysis in Viral Infectious Diseases

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Point-of-Care Microdevices for Blood Plasma Analysis in Viral Infectious Diseases Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Point-of-Care Microdevices for Blood Plasma Analysis in Viral Infectious Diseases
Creator	Yeh, Yin-Ting Nisic, Merisa Xia, Yiqiu Yu, X Zheng, Si-Yang
topic	covid:2226d1e1bc57ca5ff9b937f193b7315cd4d7c412#this
Source	Medline; PMC
abstract	Each year, outbreaks of viral infections cause illness, disability, death, and economic loss. As learned from past incidents, the detrimental impact grows exponentially without effective quarantine. Therefore, rapid on-site detection and analysis are highly desired. In addition, for high-risk areas of viral contamination, close monitoring should be provided during the potential disease incubation period. As the epidemic progresses, a response protocol needs tobe rapidly implemented and the virus evolution fully tracked. For these scenarios, point-of-care microdevices can provide sensitive, accurate, rapid and low-cost analysis for a large population, especially in handling complex patient samples, such as blood, urine and saliva. Blood plasma can be considered as a mine of information containing sources and clues of biomarkers, including nucleic acids, immunoglobulin and other proteins, as well as pathogens for clinical diagnosis. However, blood plasma is also the most complicated body fluid. For targeted plasma biomarker detection or untargeted plasma biomarker discovery, the challenges can be as difficult as identifying a needle in a haystack. A useful platform must not only pursue single performance characteristics, but also excel at multiple performance parameters, such as speed, accuracy, sensitivity, selectivity, cost, portability, reliability, and user friendliness. Throughout the decades, tremendous progress has been made in point-of-care microdevices for viral infectious diseases. In this paper, we review fully integrated lab-on-chip systems for blood analysis of viral infectious disease.
has issue date	2014-05-31(xsd:dateTime)
bibo:doi	10.1007/s10439-014-1044-2
bibo:pmid	24879614
has license	no-cc
sha1sum (hex)	2226d1e1bc57ca5ff9b937f193b7315cd4d7c412
schema:url	https://doi.org/10.1007/s10439-014-1044-2
resource representing a document's title	Point-of-Care Microdevices for Blood Plasma Analysis in Viral Infectious Diseases
has PubMed Central identifier	PMC7088150
has PubMed identifier	24879614
schema:publication	Ann Biomed Eng
resource representing a document's body	covid:2226d1e1bc57ca5ff9b937f193b7315cd4d7c412#body_text
is http://vocab.deri.ie/void#inDataset of	https://covidontheweb.inria.fr:4443/about/id/http/ns.inria.fr/covid19/2226d1e1bc57ca5ff9b937f193b7315cd4d7c412
is schema:about of	named entity 'highly' named entity 'sensitivity' named entity 'viral' named entity 'discovery' named entity 'contamination' named entity 'paper' named entity 'diagnosis' named entity 'impact' named entity 'illness' named entity 'pathogens' named entity 'Infectious Diseases' named entity 'VIRAL INFECTIOUS DISEASES' named entity 'PAST' named entity 'INFORMATION' named entity 'SENSITIVITY' named entity 'PARAMETERS' named entity 'PROGRESS' named entity 'CLINICAL DIAGNOSIS' named entity 'LAB' named entity 'PORTABILITY' named entity 'BODY FLUID' named entity 'VIRAL INFECTIOUS DISEASES' named entity 'COST' named entity 'USER' named entity 'SELECTIVITY' named entity 'ECONOMIC LOSS' named entity 'NEEDS' named entity 'PROTOCOL' named entity 'CONTAINING' named entity 'RAPIDLY' named entity 'QUARANTINE' named entity 'PLATFORM' named entity 'LEARNED' named entity 'SINGLE' named entity 'CHARACTERISTICS' named entity 'BIOMARKER' named entity 'ANALYSIS' named entity 'NEEDLE' named entity 'RELIABILITY' named entity 'VIRUS' named entity 'REVIEW' named entity 'RAPID' named entity 'HANDLING' named entity 'HAYSTACK' named entity 'BIOMARKERS' named entity 'CHALLENGES' named entity 'DEATH' named entity 'DETECTION' named entity 'FULLY' named entity 'LARGE' named entity 'POINT-OF-CARE' named entity 'SCENARIOS' named entity 'USEFUL' named entity 'DISEASE' named entity 'INCUBATION PERIOD' named entity 'LOW' named entity 'VIRAL INFECTIONS' named entity 'BLOOD' named entity 'THESE' named entity 'AREAS' named entity 'POINT-OF-CARE' named entity 'TARGETED' named entity 'EVOLUTION' named entity 'INTEGRATED' named entity 'PATIENT' named entity 'DISABILITY' named entity 'PATHOGENS' named entity 'POPULATION' named entity 'CAUSE' named entity 'SALIVA' named entity 'POINT' named entity 'POTENTIAL' named entity 'SAMPLES' named entity 'COMPLICATED' named entity 'CLOSE'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software